Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer. 2018 Oct 1;124(23):4529–4537. doi: 10.1002/cncr.31772

Parental Distress and Desire for Information about Long-term Implications of Pediatric Cancer Treatment

Katie A Greenzang 1,2,3, Angel M Cronin 2, Tammy Kang 4, Jennifer W Mack 1,2,3
PMCID: PMC6289673  NIHMSID: NIHMS987576  PMID: 30276800

Abstract

BACKGROUND:

Parents of children with cancer have unmet information needs about future limitations resulting from cancer or its treatment. Prior research shows that clinicians focus on acute effects of therapy rather than long-term limitations in early care discussions, partly due to worries of causing distress. The validity of concerns about distress is unknown. We evaluated parental distress associated with information about future limitations, and the extent to which distress is associated with information preferences.

METHODS:

We surveyed 355 parents of children with cancer within 3 months of diagnosis, and the children’s physicians, at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Children’s Hospital of Philadelphia. Our primary outcome was parental distress associated with information about long-term limitations.

RESULTS:

46% of parents found information about future limitations to be extremely or very upsetting. In multivariate analysis, parents were more likely to consider information about future limitations distressing if they also found prognostic information upsetting (OR 5.36, p<0.001), struggled to accept their child’s illness (OR 2.57, p<0.001), or had depression (OR 1.79, p=0.01). However, 92% of parents considered information about potential future limitations to be extremely/very important. Those who found information about future limitations distressing were more likely to consider it important (96% vs 89%, p=0.03), and to desire a precise understanding of their child’s risks (92% vs 80%, p=0.001).

CONCLUSION:

Though information about future limitations caused by cancer treatment is upsetting to many parents, most parents desire this information, and those who are distressed are more likely to value this information.

Keywords: parents, pediatric, cancer, communication, survivorship, late effects

Precis:

Though information about future impairment as a result of pediatric cancer or its treatment is upsetting to many parents, parents desire this information from the time of diagnosis, and those who are distressed consider this information particularly important.

Background:

The time surrounding a child’s cancer diagnosis can be overwhelming to parents.1 Beyond the news of the diagnosis, early treatment conversations frequently touch on sensitive topics such as the child’s prognosis and the short- and long-term risks of therapy.13 Parents who are emotionally overwhelmed may struggle to process and incorporate the news of the cancer and the fact that treatment may have life-long consequences.4

Prior work suggests that parents value information about late effects from the time of diagnosis,3,5,6 but parents feel they receive sub-optimal information about future implications of their children’s treatment.7 This may be in part because providers offer less information about late effects than acute toxicities during early treatment conversations.8 Furthermore, clinicians often describe probabilities of specific late effects of treatment by individual chemotherapeutic agents, yet parents worry about the functional implications of the treatment as a whole9 and the potential impact on their children’s lives.10

The gap between parent communication preferences about future limitations, and the information they receive, may in part be due to provider concerns about discussing potential impairment. Providers often hesitate to discuss late effects throughout the cancer care continuum due to concerns about overwhelming patients with information and causing distress.11,12 Furthermore, many physicians find it stressful to anticipate and communicate a patient’s likely outcomes,13 and fear taking away hope.14 Even in survivorship clinics, oncologists tend to focus on current symptoms, rather than providing information about potential future health risks.15

As rates of cure for childhood cancer continue to improve, it is ever more important that we meet parents’ information needs regarding the long-term health implications of cancer and its treatment. Currently, more than 80% of children with cancer will become long-term survivors,16 and most will experience at least one late effect of cancer treatment.17 In this study, we sought to evaluate the emotional impact of early conversations about future limitations of cancer treatment. We hypothesized that parents, particularly parents of children with a high likelihood of long-term survival, would consider this information upsetting but important. We also investigated factors associated with parental distress about future impairment, and the extent to which distress is associated with information preferences.

Methods:

We surveyed parents of children with cancer and the children’s pediatric oncologists at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Children’s Hospital of Philadelphia about their medical communication experiences. Questionnaires were administered between November 2008 and April 2014. Parents were approached about participation 1 to 6 weeks after initial diagnosis, and surveys were administered within 12 weeks of the child’s diagnosis. Eligibility criteria included child ≤18 years of age, parent able to read English or Spanish, and permission to approach granted by the child’s primary oncologist. Eligible parents were approached in person during clinic visits or by mail, and given a letter describing participation, the questionnaire, and a postage-paid postcard to decline participation. Parents who did not respond initially were approached a second time. One parent per child completed the survey. After a parent completed a survey, their child’s primary oncologist was approached with the paired physician survey. As a token of appreciation, participating parents received a $10 gift card, and physician participants received a $5 gift card. The institutional review boards of the Dana-Farber Cancer Institute and Children’s Hospital of Philadelphia approved this study.

Parent and physician survey instruments utilized items or modified items drawn from previously developed questionnaires.7,18,19 Limited novel items were developed after literature review, employing general principles of survey design. The 75-item parent survey was pilot tested with parents to assess face and content validity, and took approximately 30–40 minutes to complete. Parent and oncologist surveys were available in paper-and-pencil or electronic format per participant preference; parent surveys were available in English or Spanish. Surveys were initially written in English, translated into Spanish, then back-translated into English to ensure translation accuracy.

Study Outcomes:

The primary outcome for this analysis was parental distress associated with information about future limitations, assessed by a single survey item. Parents were asked how upsetting it was “to know information about how likely it is that cancer or its treatment may affect your child’s life in the future,” with response options of extremely, very, somewhat, a little, and not at all. This item was a modified version of an item previously used to assess distress associated with prognostic information.18

The secondary outcome was parent information preferences about future limitations, assessed using 2 previously utilized items.20 Parents were asked the importance of knowing “how likely it is that cancer or its treatment may affect your child’s life in the future” and the importance of “having a precise understanding” of the likelihood of future limitations.

Explanatory factors:

We assessed the following factors we hypothesized may be associated with parents finding future limitations information upsetting:

  • Parent perception of information quality using a previously developed 5-item scale (α=0.87) with items querying the quality of information received about treatment, cause of cancer, likelihood of cure, likelihood of future limitations, and overall, with response options excellent/good/satisfactory/fair/poor.21

  • Parent perception of communication quality utilizing a previously developed scale (α=0.76) which asked how often the oncologist gives understandable answers to questions, takes adequate time to answer questions, and conveys information in a sensitive manner, with response options never/sometimes/usually/always.21

  • Trust in the child’s oncologist using an item from the Trust in Physician scale.22,23

  • Parents and physicians were asked the child’s likelihood of cure, and likelihood of experiencing future limitations in “physical abilities (such as difficulty exercising),” “intelligence (such as difficulty with schoolwork),” and “quality of life (such as difficulty enjoying time with family or friends).”20,24 Physician-reported prognosis estimations were dichotomized as “favorable” (>75% chance of cure), or “less favorable” (<75% chance of cure) to approximate median survival estimates for all children with cancer. As described in prior analyses, physician-reported likelihood of future limitations in each domain was trichotomized as “high risk” (≥50% chance), “moderate risk” (10–49% chance of future limitation), and “low risk” (≤10% chance).25

  • Distress related to prognostic information by asking parents “how upsetting is it to you to know information about your child’s likelihood of cure?” (extremely/ very/somewhat/a little/not at all).18

  • Parental peaceful acceptance and struggle with illness using the validated PEACE scales; the 7-item struggle with illness sub-scale (α=0.81), and the 5-item peaceful acceptance sub-scale (α=0.78).26

  • Parental depression and anxiety using the 14-item Hospital Anxiety and Depression Scale (HADS, α=0.92).27,28

  • Parent/child attributes: Parent sex, age, educational level, and race/ethnicity were obtained by questionnaire. Previously validated scales were used to assess parent dispositional optimism (6-item),29 decisional regret (5-item),30 and decision-making preferences and role (2-item).31 . Child’s sex, diagnosis, date of diagnosis, and date of birth were obtained by medical record review.

Statistical Methods:

Parental distress associated with information about potential future limitations was dichotomized as highly upsetting (extremely/very) vs. somewhat/a little/not at all. Univariable and multivariable logistic regression were used to evaluate factors associated with parental distress. Backwards selection was used to construct the multivariable model, setting the significance level for removal to 0.05, and including parental education, parent race/ethnicity and child diagnosis category in the model regardless of statistical significance. Variances of parameter estimates were obtained using a sandwich estimator to correct for within-physician clustering. Similar univariable analyses were performed to investigate if information preferences differ by parental distress related to future limitations.

Item non-response was ≤7% for all items. Missing values were imputed by multiple imputation by chained equations, using the -ice-command in Stata. Imputed values were used only for regression analyses, and not for descriptive statistics; moreover, values for the outcome variable (parental distress) were not imputed. Statistical analyses were conducted using Stata version 13.1 (StataCorp, College Station, TX).

Results:

Sixty-eight percent (382/565) of eligible parents completed the survey within 12 weeks of their child’s diagnosis (mean 6 weeks post-diagnosis), and 95 oncologists completed paired surveys for 361/382 (95%). Six surveys were excluded as the parent did not respond to the primary outcome of the present analysis, for a final cohort of 355 parent-physician pairs. Parents of children with hematologic malignancies, extra-cranial solid tumors, and brain tumors were equally likely to participate, although there was a borderline association toward decreased participation of parents of children with brain tumors (p=0.07). The majority of parent respondents were female, married and highly educated (Table 1). Oncologists considered 22% of children at high risk of physical limitations, 9% high risk for impaired intelligence, and 6% high risk for limitations in quality of life.

Table 1.

Characteristics of participating parents and their children (N=355)

N (%)
Parent age*
  <30 38(11)
  30-39 137(39)
  40-49 134(39)
  50+ 39(11)
Parent gender*
  Female 285(81)
  Male 67(19)
Parent race/ethnicity*
  White 276(78)
  Black 23(7)
  Hispanic 28(8)
  Other 25(7)
Parent education*
  <College graduate 123(35)
  College graduate 137(39)
  Graduate/professional school 88(25)
Parent marital status*
  Married/living as married 293(84)
  Other 56(16)
Child age at diagnosis (years)
  0-2 96(27)
  3-6 71(20)
  7-12 79(22)
  13-18 109(31)
Child gender*
  Male 156(44)
  Female 198(56)
Diagnosis
  Hematologic malignancies 174(49)
  Solid tumor 138(39)
  Brain tumor 43(12)
Physician-rated prognosis
  Favorable 216(61)
  Unfavorable 139(39)
Site
  Boston 263(74)
  Philadelphia 92(26)
Language of Survey Completion
  English 341(96)
  Spanish 14(4)
*

Missing data include child gender (N=1); parental age (N=7); parental gender (N=3); parental race/ethnicity (N=3); parental education (N=7); and parental marital status (N=6).

Nearly half (46%, 165/355) of parents found information about potential future limitations due to cancer or its treatment to be extremely or very upsetting. In bivariable analyses, parental distress related to future limitations was not significantly associated with physician estimates of the child’s prognosis or the child’s risk of future limitations (Table 2). However, parents who found prognostic information upsetting (35%, 121/348) also tended to find information about future limitations upsetting (OR 5.64; 95% CI 3.78–8.42). Distress about future limitations was also more likely among parents who struggled to accept their child’s illness (OR 2.95; 95% CI 1.9–4.56), and those with depression (OR 2.52; 95% CI 1.65–3.85), and anxiety (OR 1.87, 95% CI 1.17–2.98). In contrast, parents reported less distress if they held a passive role in decision-making relative to the oncologist (OR 0.57; 95% CI 0.36–0.89), and if they reported peaceful acceptance of the child’s illness (OR 0.43; 95% CI 0.3–0.63).

Table 2.

Bivariable analysis of factors associated with parents finding it “extremely” or “very” upsetting to know information about how likely it is that cancer or its treatment may affect their child’s life in the future.

Number of patients* Unadjusted % extremely/very upset Unadjusted Odds Ratio 95% CI P Value
Prognosis and Prognostic Communication
Physician-Estimated Prognosis
  Favorable (>75% chance of cure) 216 44 1.00
  Unfavorable 139 50 1.23 0.86-1.76 0.25
Distress related to prognostic information
  Somewhat-Not at all 227 32 1.00
  Extremely/very upset 121 72 5.64 3.78-8.42 <0.001

Risk of Future Limitations: Physician-rated likelihood of impairment in
Intelligence
  Low risk 121 40 1.00
  Moderate risk 155 52 1.54 0.96-2.48 0.19
  High risk 76 45 1.14 0.70-1.87
Physical function
  Low risk 175 43 1.00
  Moderate risk 145 50 1.31 0.81-2.12 0.47
  High risk 32 44 1.00 0.51-1.96
Quality of life
  Low risk 167 43 1.00
  Moderate risk 163 52 1.40 0.85-2.31 0.22
  High risk 22 36 0.80 0.28-2.26

Information, Communication and Decision-Making Experiences
Quality of information received about future limitations
  Satisfactory-Poor 126 44 1.00
  Excellent-good 220 47 1.17 0.77-1.80 0.46
Overall information quality
  Low 143 50 1.00
  High 194 44 0.83 0.55-1.24 0.36
Communication quality
  Low 170 42 1.00
  High 178 49 1.35 0.85-2.14 0.20
Trust in physician
  Not completely 107 44 1.00
  Completely 246 47 1.13 0.65-1.95 0.67
Held ideal role in decision-making
  No 130 45 1.00
  Yes 218 47 1.08 0.69-1.70 0.73
Held a passive role in decision-making
  No 252 50 1.00
  Yes 97 36 0.57 0.36-0.89 0.01
Decisional Regret
  Low 289 45 1.00
  High 66 55 1.49 0.91-2.42 0.11

Parent and Child Characteristics
Child diagnosis
  Hematologic malignancy 174 45 1.00
  Extra-cranial solid tumor 138 46 1.01 0.63-1.62 0.62
  Brain tumor 43 53 1.38 0.74-2.57
Child age at diagnosis
  0-2 96 51 1.00
  3-6 71 48 0.88 0.52-1.49 0.68
  7-12 79 44 0.76 0.42-1.39
  13-18 109 43 0.73 0.45-1.17
Child gender
  Female 156 49 1.00
  Male 198 44 0.80 0.50-1.26 0.34
Parent education
  <College graduate 123 53 1.00
  College graduate 137 47 0.80 0.53-1.20 0.13
  Graduate/professional school 88 39 0.56 0.32-0.98
Parent race/ethnicity*
  White 276 46 1.00
  Black 23 48 1.07 0.49-2.30 0.49
  Hispanic 28 61 1.71 0.75-3.90
  Other 25 40 0.75 0.30-1.90

Parent Psychological Factors
Dispositional optimism
  Low 166 49 1.00
  High 189 44 0.80 0.55-1.16 0.25
Peaceful acceptance of illness
  Low 167 58 1.00
  High 172 38 0.43 0.30-0.63 <0.001
Struggle with illness
  Low 149 32 1.00
  High 179 58 2.95 1.90-4.56 <0.001
Parental depression
  HADS score not suggestive 241 40 1.00
  Suggestive 103 62 2.52 1.65-3.85 <0.001
Parental anxiety
  HADS score not suggestive 156 37 1.00
  Suggestive 177 53 1.87 1.17-2.98 0.009
*

Numbers may not sum to 355 due to missing values. Imputed values were used for logistic regression.

In a multivariable logistic regression model (Table 3), parents were more likely to find information about future limitations upsetting if they were upset by prognostic information (OR 5.36; 95% CI 3.34–8.6), if they struggled to accept their child’s illness (OR 2.57; 95% CI 1.53–4.31), and if they had HADS scores suggestive of depression (OR 1.79; 95% CI 1.18–2.72). Parents who felt they held a passive role in decision making were less likely to be upset by future limitations information (OR 0.52; 95% CI 0.3–0.94).

Table 3.

Factors associated with parents finding information about future limitations extremely/very upsetting in multivariable logistic regression. The model was determined using a backwards selection procedure where the significance level for removal from the model was set at 0.05; parental education, parent race/ethnicity and diagnosis category were forced into the model regardless of statistical significance. Odds ratios >1 represent a higher likelihood of finding information about future limitations to be extremely/very upsetting.

Odds Ratio 95% CI P Value
Distress related to prognostic information
  Somewhat-Not at all 1.00
  Extremely-very upset 5.36 3.34-8.60 <0.001

Struggle with illness
  Low 1.00
  High 2.57 1.53-4.31 0.001

Parental depression
  HADS score not suggestive 1.00
  Suggestive 1.79 1.18-2.72 0.01

Held a passive role in decision-making
  No 1.00
  Yes 0.52 0.30-0.94 0.03

Parent education
  <College graduate 1.00
  College graduate 0.63 0.38-1.03
  Graduate/professional school 0.69 0.38-1.23 0.13

Parent race/ethnicity*
  White 1.00
  Black 1.30 0.50-3.40
  Hispanic 0.97 0.38-2.48
  Other 0.59 0.26-1.32 0.56

Child diagnosis
  Hematologic malignancies 1.00
  Solid tumor 0.96 0.57-1.63
  Brain tumor 0.86 0.41-1.80 0.92

Despite the prevalence of distress, 92% of parents thought information about long-term limitations was extremely or very important, and 86% desired a precise understanding of possible future limitations. Parents who found information about future limitations to be extremely or very upsetting were more likely to consider this information important (OR 2.83; 95% CI 1.12–7.15) and more likely to value a precise understanding of the risk of future limitations (OR 2.90; 95% CI 1.58–5.29) relative to parents who were less upset by this information (Table 4).

Table 4.

Association between parents finding information about future limitations extremely or very upsetting and parent information preferences. N=355.

Number of patients Importance of information about possible future limitations Importance of having a precise understanding of possible future limitations

Unadjusted % “extremely or very important” Unadjusted OR (95% CI) P value Unadjusted % “extremely or very important” Unadjusted OR (95% CI) P value
Parental distress related to future limitations information
  Somewhat-not at all 190 89 1.00 80 1.00
  Extremely/very 165 96 2.83 (1.12-7.15) 0.03 92 2.90 (1.58-5.29) 0.001

Discussion:

Nearly half of the parents in our study considered information about future limitations resulting from cancer or its treatment to be upsetting. However, those who were distressed by this information expressed greater desire for detailed information about long-term outcomes. Many oncologists worry that providing information about potential future limitations may upset parents,11,12 and while this work supports this as a legitimate concern, our study suggests that parental distress should not be considered a reason to avoid conversations. Instead, parents who are distressed may need more information, or an opportunity to have continued discussions over time.

We identified risk factors for finding information about future limitations upsetting. For example, parents who experience depression, those who struggle with their child’s diagnosis, and those who are upset by prognostic information may benefit from added emotional support overall, and particular care in presenting information about future limitations. Additionally, we found that parents who held a more passive role in decision-making were less likely to be upset by late effects information. Research suggests that individuals feel greater regret for decisions for which they feel more responsibility,32 a phenomenon that may be at work here. Parents who felt less engaged in decisions may have felt less responsibility for potential outcomes, and subsequently less distressed. Notably, communication and information quality were not associated with distress.

Although we identified an association between distress and desire for more detailed information about long-term outcomes, we do not know the direction of this association and cannot speak to causation. Prior work suggests some potential mechanisms for the association. First, it is possible that inadequate information contributes to distress. Though we did not find an association between parent perception of information quality and distress, we do not have detailed information on what was said. Prior work in prognostic communication has identified greater upset among parents who report lack of prognostic disclosure, and those who are dissatisfied with the quantity of information received.18 Parents who feel they do not have enough information about the potential long-term implication of therapy may presume the worst and worry accordingly. Alternatively, distress may impair a parent’s ability to process or remember the information presented. We previously found that parents who were upset by information about future limitations were less likely to understand their child’s risk of impairment, relative to parents who were less upset by such information,25 suggesting that parental distress may have implications beyond the immediate emotionality of the information.

We also found that parents who found information about long-term limitations distressing were more likely to find prognostic information distressing, reinforcing the parallels between these types of information. Studies of prognostic disclosure have shown that a subset of parents find prognostic information quite upsetting, however parents value prognostic information, and receiving information about prognosis does not diminish hope.18,21,33 We hypothesized that parents of children with good prognoses might be most worried about future functional limitations, but prognosis was not significantly associated with concerns about future limitations. We also found that a higher risk of functional impairment was not significantly associated with increased parental distress. Therefore, distress may reflect the emotional experience of the parent more than the medical reality for the child.

Parents expressed a strong desire for information they found distressing, but our study did not investigate how this information could be shared in a less upsetting way. Further research should explore how best to convey information about potential functional impairment in a way that accurately conveys risks while meeting parents’ emotional needs. Studies audio- or video-recording early conversations about long-term effects of treatment could be utilized to help identify best practices and explore the impact of spoken communication on distress. In the meantime, clinicians should consider asking parents how much information they desire, and with what level of detail, and tailor their information delivery accordingly.

Our findings should be interpreted in the context of potential limitations. We surveyed parents of children with many different cancer diagnoses with different risks of late effects, and some long-term limitations may be more distressing than others. We asked about general categories of future limitations, as opposed to exploring distress associated with specific late effects, in part to address the varied late effects that patients might face, and as pilot testing revealed these functional outcomes to be more important to parents. Our study surveyed largely Caucasian, highly-educated parents at two large pediatric cancer centers, raising concerns about generalizability. Future research should explore the unique information needs and preferences of more vulnerable populations. While we did not capture the detailed content of the initial discussions between parents and providers, the majority of children with cancer are enrolled on clinical trials with standardized informed consent documents.34 These documents are often utilized during discussions of potential long-term effects of therapy, suggesting some uniformity of information provided across centers. We have limited information about parents who declined participation, so we do not know if they differed from our study sample in meaningful ways. Lastly, this study did not explore patient perspectives. Survivors of childhood cancer with unmet information needs about long-term outcomes are more likely to experience depression, anxiety and inferior health-related quality of life.3537 We focused on parents in this analysis as they are the primary decision-makers for their children, but adolescent and young adult patient perspectives on information delivery and distress associated with future limitations should be explored in future work.

Though emotional to learn about, parents desire early information about long-term functional implications of cancer and its treatment. Risks of future impairment have typically been addressed in depth after treatment completion and during survivorship, yet parents wish to hear this information in early treatment discussions as they consider it germane to decision-making.9 Information about potential functional limitations is also crucial to preparing families for their children’s future health needs.20 While many parents in our study found information about future limitations upsetting, limited discussions of the long-term implications of cancer treatment do not meet parent preferences for early, detailed information. Best practices for these conversations must be investigated and tested so that we can impart difficult information honestly while also supporting its emotional impact.

Acknowledgments

Funding: NIH AHRQ K12 HS022986(KAG); Conquer Cancer Foundation Career Development Award (JWM); ACS Mentored Research Scholar Grant MRSG-08–010-01-CPPB(JWM).

Footnotes

Conflicts of Interest: None

Informed Consent was obtained from each participant.

References

  • 1.Levi RB, Marsick R, Drotar D, et al. : Diagnosis, disclosure, and informed consent: learning from parents of children with cancer. J Pediatr Hematol Oncol 22:3–12, 2000 [DOI] [PubMed] [Google Scholar]
  • 2.Mack JW, Grier HE: The Day One Talk. J Clin Oncol 22:563–6, 2004 [DOI] [PubMed] [Google Scholar]
  • 3.Kessel RM, Roth M, Moody K, et al. : Day One Talk: parent preferences when learning that their child has cancer. Support Care Cancer 21:2977–82, 2013 [DOI] [PubMed] [Google Scholar]
  • 4.Eden OB, Black I, MacKinlay GA, et al. : Communication with parents of children with cancer. Palliat Med 8:105–14, 1994 [DOI] [PubMed] [Google Scholar]
  • 5.Trask CL, Welch JJ, Manley P, et al. : Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment. Pediatr Blood Cancer 52:273–9, 2009 [DOI] [PubMed] [Google Scholar]
  • 6.Sisk BA, Greenzang KA, Kang TI, et al. : Longitudinal parental preferences for late effects communication during cancer treatment. Pediatr Blood Cancer 65, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kaye E, Mack JW: Parent perceptions of the quality of information received about a child’s cancer. Pediatr Blood Cancer 60:1896–901, 2013 [DOI] [PubMed] [Google Scholar]
  • 8.Ramirez LY, Huestis SE, Yap TY, et al. : Potential chemotherapy side effects: what do oncologists tell parents? Pediatr Blood Cancer 52:497–502, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Greenzang KA, Dauti A, Mack JW: Parent perspectives on information about late effects of childhood cancer treatment and their role in initial treatment decision making. Pediatr Blood Cancer 65:e26978, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Feraco AM, Brand SR, Gagne J, et al. : Development of the “Day 100 Talk”: Addressing existing communication gaps during the early cancer treatment period in childhood cancer. Pediatr Blood Cancer 65:e26972, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Simon C, Eder M, Raiz P, et al. : Informed consent for pediatric leukemia research: clinician perspectives. Cancer 92:691–700, 2001 [DOI] [PubMed] [Google Scholar]
  • 12.Cox A, Faithfull S: ‘They’re survivors physically but we want them to survive mentally as well’: health care professionals’ views on providing potential late effect information. Support Care Cancer 21:2491–7, 2013 [DOI] [PubMed] [Google Scholar]
  • 13.Christakis NA, Iwashyna TJ: Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 158:2389–95, 1998 [DOI] [PubMed] [Google Scholar]
  • 14.Gordon EJ, Daugherty CK: ‘Hitting you over the head’: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–68, 2003 [DOI] [PubMed] [Google Scholar]
  • 15.Mellblom AV, Korsvold L, Finset A, et al. : Providing Information About Late Effects During Routine Follow-Up Consultations Between Pediatric Oncologists and Adolescent Survivors: A Video-Based, Observational Study. J Adolesc Young Adult Oncol 4:200–8, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smith MA, Altekruse SF, Adamson PC, et al. : Declining childhood and adolescent cancer mortality. Cancer 120:2497–506, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Phillips SM, Padgett LS, Leisenring WM, et al. : Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev 24:653–63, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mack JW, Wolfe J, Grier HE, et al. : Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24:5265–70, 2006 [DOI] [PubMed] [Google Scholar]
  • 19.Mack JW, Cronin AM, Kang TI: Decisional Regret Among Parents of Children With Cancer. J Clin Oncol 34:4023–4029, 2016 [DOI] [PubMed] [Google Scholar]
  • 20.Greenzang KA, Cronin AM, Mack JW: Parental preparedness for late effects and long-term quality of life in survivors of childhood cancer. Cancer 122:2587–94, 2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mack JW, Wolfe J, Cook EF, et al. : Hope and prognostic disclosure. J Clin Oncol 25:5636–42, 2007 [DOI] [PubMed] [Google Scholar]
  • 22.Anderson LA, Dedrick RF: Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep 67:1091–100, 1990 [DOI] [PubMed] [Google Scholar]
  • 23.Hall MA, Camacho F, Dugan E, et al. : Trust in the medical profession: conceptual and measurement issues. Health Serv Res 37:1419–39, 2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mack JW, Cook EF, Wolfe J, et al. : Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol 25:1357–62, 2007 [DOI] [PubMed] [Google Scholar]
  • 25.Greenzang KA, Cronin AM, Kang T, et al. : Parent understanding of the risk of future limitations secondary to pediatric cancer treatment. Pediatr Blood Cancer 65:e27020, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mack JW, Nilsson M, Balboni T, et al. : Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE): validation of a scale to assess acceptance and struggle with terminal illness. Cancer 112:2509–17, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Beck AT, Ward CH, Mendelson M, et al. : An inventory for measuring depression. Arch Gen Psychiatry 4:561–71, 1961 [DOI] [PubMed] [Google Scholar]
  • 28.Beck AT, Epstein N, Brown G, et al. : An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–7, 1988 [DOI] [PubMed] [Google Scholar]
  • 29.Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 67:1063–78, 1994 [DOI] [PubMed] [Google Scholar]
  • 30.Brehaut JC, O’Connor AM, Wood TJ, et al. : Validation of a decision regret scale. Med Decis Making 23:281–92, 2003 [DOI] [PubMed] [Google Scholar]
  • 31.Degner LF, Sloan JA: Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 45:941–50, 1992 [DOI] [PubMed] [Google Scholar]
  • 32.Coricelli G, Critchley HD, Joffily M, et al. : Regret and its avoidance: a neuroimaging study of choice behavior. Nat Neurosci 8:1255–62, 2005 [DOI] [PubMed] [Google Scholar]
  • 33.Nyborn JA, Olcese M, Nickerson T, et al. : “Don’t Try to Cover the Sky with Your Hands”: Parents’ Experiences with Prognosis Communication About Their Children with Advanced Cancer. J Palliat Med 19:626–31, 2016 [DOI] [PubMed] [Google Scholar]
  • 34.Aristizabal P, Singer J, Cooper R, et al. : Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities. Pediatr Blood Cancer 62:1337–44, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gianinazzi ME, Essig S, Rueegg CS, et al. : Information provision and information needs in adult survivors of childhood cancer. Pediatr Blood Cancer 61:312–8, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vetsch J, Fardell JE, Wakefield CE, et al. : “Forewarned and forearmed”: Long-term childhood cancer survivors’ and parents’ information needs and implications for survivorship models of care. Patient Educ Couns 100:355–363, 2017 [DOI] [PubMed] [Google Scholar]
  • 37.DeRouen MC, Smith AW, Tao L, et al. : Cancer-related information needs and cancer’s impact on control over life influence health-related quality of life among adolescents and young adults with cancer. Psychooncology 24:1104–15, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES